Science Explorer Back to mapMap
Discussion
Researcher · Genetika · Russia

Anna V Gerasimova

Anna V Gerasimova publishes mostly in Molecular Biology, Infectious Diseases and Genetics, on topics such as Genomics and Phylogenetic Studies, RNA and protein synthesis mechanisms and Bacterial Genetics and Biotechnology.

ORCID 0000-0002-6307-7086 OpenAlex
World rank
#2,003,907
of 7,710,434 ranked researchers
Rank in Russia
#6,129
of 179,717
Works
32
Citations
15k
Citations per work
472.0
h-index
14
i10-index 15Top 55% in Molecular Biology
Anna V Gerasimova

What does Anna V Gerasimova research?

Anna V Gerasimova's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (24%), Immunology and Microbiology (4%).

Life Sciences: 15 works · 47.1% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 43.6% of their workMolecular Biology: 10 works · 31.8% of their workGenetics: 4 works · 11.8% of their workImmunology and Microbiology: 1 works · 3.5% of their workImmunology: 1 works · 3.5% of their workEverything else: 9 works · 29.4% of their workHealth Sciences: 8 works · 23.5% of their workMedicine: 8 works · 23.5% of their workInfectious Diseases: 4 works · 12.9% of their workHematology: 2 works · 5.9% of their workEpidemiology: 2 works · 4.7% of their workTHEIR WORKAnna V Gerasimova32works
Life Sciences47%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1443.6%
    2. Immunology and Microbiology13.5%
  2. Everything else929.4%
    1. Medicine823.5%
  1. 1Molecular Biology32% of their works
  2. 2Infectious Diseases13% of their works
  3. 3Genetics12% of their works
  4. 4Hematology6% of their works
  5. 5Epidemiology5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Anna V Gerasimova's research?

The keywords of their largest research topics: Antibiotic Resistance, Diagnosis, Epidemiology, Ribosome, RNA-Seq, sequence alignment, Translation and Bacterial Physiology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Antibiotic Resistance82 topics
  2. Diagnosis72 topics
  3. Epidemiology72 topics
  4. RNA-Seq61 topic
  5. Ribosome61 topic
  6. Translation61 topic
  7. sequence alignment61 topic
  8. Bacterial Physiology51 topic
  9. Gene Regulation51 topic
  10. AML41 topic
  11. Acute Myeloid Leukemia41 topic
  12. Mycobacterium tuberculosis41 topic
  13. Tuberculosis41 topic
  14. JAK2 Mutation31 topic
  15. Marine Microbes31 topic
  16. Microbial Biogeography31 topic
  17. Mycobacterium avium31 topic
  18. Myelofibrosis31 topic
  19. Nontuberculous Mycobacteria31 topic

Where does Anna V Gerasimova work?

Anna V Gerasimova's main affiliation in the publication record is Genetika, Russia.

How many publications and citations does Anna V Gerasimova have?

OpenAlex counts 32 works and 15,103 citations for Anna V Gerasimova, an h-index of 14, ranking #2,003,907 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anna V Gerasimova. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.